- Added to Email Alerts
Atopic Dermatitis
Latest News View All
-
AlertAnzupgo Approved in Europe for Severe Hand Eczema
-
Delgocitinib Effective for Hand Eczema in Phase 3 Studies
-
Cendakimab Clears Skin in Adults With Atopic Dermatitis
-
AD in Older Adults: Common, Unique, Challenging to Manage
-
AlertFDA Approves Topical Eczema Rx for Ages 6 or Older
-
Dupilumab Safe, Effective Over 5 Years in Moderate-Severe AD
-
Review: Dupilumab Benefits Kids With AD and Alopecia Areata
-
Dupilumab Effective in PPI-Refractory Pediatric EoE
Perspective View All
Journal Articles View All
-
Shingles Prevention in Immunocompromised Dermatology Patients
-
Utilization of Topical Ruxolitinib in Dermatology
-
Laundry Detergent as a Cause of Allergic Contact Dermatitis
-
Evolving Story of JAK Inhibitors for Treating Alopecia Areata
-
Mpox in Young Woman With No Epidemiologic Risk Factors
-
Antibiotic Resistance in Dermatology: Combating Resistance